Rosalin Cooper
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
Papers in
-
- Immune Cell Function and Interaction 3
- T-cell and B-cell Immunology 2
-
- Single-cell and spatial transcriptomics 2
- Co-authors
- R. T. Chlebowski (1 shared paper)H.T. Mouridsen (1 shared paper)Aman U. Buzdar (1 shared paper)John Crowley (1 shared paper)Andrea Bianco (1 shared paper)Francesco Boccardo (1 shared paper)Kasper Langebjerg Andersen (1 shared paper)I. Craig Henderson (1 shared paper)
- Journals
- Blood (2 papers)British Journal of Cancer (2 papers)Nature Communications (1 paper)Science Immunology (1 paper)Cancer Research (1 paper)
- Partner nations
- United KingdomItalyUnited States
In The Last Decade
Rosalin Cooper
20 papers receiving 932 citations
Peers
Comparison fields: 5 of 84
- Cancer Research 267
- Oncology 429
- Immunology 160
- Genetics 188
- Pathology and Forensic Medicine 68
Countries citing papers authored by Rosalin Cooper
This map shows the geographic impact of Rosalin Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosalin Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosalin Cooper more than expected).
Fields of papers citing papers by Rosalin Cooper
This network shows the impact of papers produced by Rosalin Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosalin Cooper. The network helps show where Rosalin Cooper may publish in the future.
Co-authors
The 25 scholars most cited alongside Rosalin Cooper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women | 1988 | 477 |
| 2 | 2020 | 206 | |
| 3 | 2021 | 51 | |
| 4 | 2004 | 35 | |
| 5 | 2021 | 35 | |
| 6 | 1976 | 35 | |
| 7 | Labetalol in the control of cardiovascular responses to electroconvulsive therapy in high-risk depressed medical patients. | 1990 | 33 |
| 8 | 2011 | 17 | |
| 9 | 2022 | 15 | |
| 10 | 1987 | 15 | |
| 11 | 2024 | 9 | |
| 12 | 1979 | 9 | |
| 13 | 2020 | 8 | |
| 14 | 2019 | 5 | |
| 15 | 2022 | 5 | |
| 16 | 2017 | 4 | |
| 17 | 2024 | 3 | |
| 18 | 2018 | 3 | |
| 19 | 2025 | 2 | |
| 20 | 2025 | 1 |
About Rosalin Cooper
Rosalin Cooper is a scholar working on Immunology, Molecular Biology, Oncology, Hematology and Psychiatry and Mental health, having authored 24 papers that have together received 968 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Immune Cell Function and Interaction (3 papers), CAR-T cell therapy research (3 papers), T-cell and B-cell Immunology (2 papers), Single-cell and spatial transcriptomics (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Acute Myeloid Leukemia Research (2 papers) and AI in cancer detection (2 papers). The work is most often cited by research in Cancer Research (267 citations), Oncology (429 citations), Immunology (160 citations), Genetics (188 citations) and Pathology and Forensic Medicine (68 citations). Rosalin Cooper has collaborated with scholars based in United Kingdom, Italy and United States. Frequent co-authors include R. T. Chlebowski, H.T. Mouridsen, Aman U. Buzdar, John Crowley, Andrea Bianco, Francesco Boccardo, Kasper Langebjerg Andersen, I. Craig Henderson, Marc Buyse and David L. Ahmann. Their work appears in journals such as Blood, British Journal of Cancer, Nature Communications, Science Immunology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.